Related Experiment Video
Updated: Jun 5, 2025

Assessment of Respiratory Function in Conscious Mice by Double-chamber Plethysmography
Published on: July 10, 2018
Cytokines reprogram airway sensory neurons in asthma
Theo Crosson1, Shreyas Bhat2, Jo-Chiao Wang1
1Département de Pharmacologie et Physiologie, Université de Montréal, Montreal, QC, Canada.
Allergic airway inflammation reprograms nociceptor neurons, making them pro-inflammatory. A compensatory mechanism involving Neuropeptide Y receptor 1 (NPY1R) limits nociceptor neuron activity during allergic reactions.
Area of Science:
- Neuroscience
- Immunology
- Respiratory Medicine
Background:
- Nociceptor neurons detect environmental dangers but contribute to allergic reactions.
- Vagal nociceptors promote immune cell infiltration and bronchial hypersensitivity in allergies.
- Mechanisms of nociceptor pro-inflammatory reprogramming in allergies remain unclear.
Purpose of the Study:
- Investigate molecular profile changes in airway nociceptors during allergic inflammation.
- Identify signals driving nociceptor reprogramming in allergic airway inflammation.
- Characterize the role of Neuropeptide Y receptor 1 (NPY1R) in this process.
Main Methods:
- Retrograde tracing and lineage reporting in a mouse model.
- Ovalbumin-induced allergic airway inflammation model.
- Screening of cytokines and neurotrophins, including IL-13 and BDNF.
- Single-cell RNA sequencing of lung immune cells.
- NPY1R knockout and chemical ablation of nociceptor neurons.
Main Results:
- Identified a specific class of inflammatory vagal nociceptors innervating airways.
- Discovered Neuropeptide Y receptor 1 (NPY1R) upregulation in these neurons.
- IL-13, IL-1β, and BDNF partially drive nociceptor reprogramming via JAK/STAT6 pathway.
- Neuropeptide Y (NPY) release in bronchoalveolar fluid limits nociceptor excitability.
- NPY1R knockout in nociceptors altered T cell infiltration in asthmatic mice.
Conclusions:
- Allergic airway inflammation reprograms airway nociceptor neurons to a pro-inflammatory phenotype.
- A compensatory mechanism involving NPY1R activation limits nociceptor neuron activity.
- Targeting NPY1R may offer therapeutic strategies for allergic airway diseases.
More Related Videos
10:39Advanced Imaging of Lung Homing Human Lymphocytes in an Experimental In Vivo Model of Allergic Inflammation Based on Light-sheet Microscopy
Published on: April 16, 2019
12:08Cultivate Primary Nasal Epithelial Cells from Children and Reprogram into Induced Pluripotent Stem Cells
Published on: March 10, 2016
Related Concept Videos
Asthma-II: Pathophysiology and Classification
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Asthma: Pathogenesis and Management
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Asthma-I: Introduction
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Inflammation
The JAK-STAT Signaling Pathway